These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2164184)

  • 41. Morphological marker of gentamicin resistance.
    Brown DF; Ockleford CD
    Lancet; 1977 Jul; 2(8028):94-5. PubMed ID: 69183
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of pefloxacin on microorganism: host cell interaction.
    Desnottes JF; Diallo N; Loubeyre C; Moreau N
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():17-26. PubMed ID: 2258345
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of pefloxacin on microbial colonization resistance in healthy volunteers.
    Vollaard EJ; Clasener HA; Janssen AJ
    Eur J Clin Microbiol Infect Dis; 1992 Mar; 11(3):257-60. PubMed ID: 1597205
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects on oral and intestinal microfloras of norfloxacin and pefloxacin for selective decontamination in bone marrow transplant patients.
    Giuliano M; Pantosti A; Gentile G; Venditti M; Arcese W; Martino P
    Antimicrob Agents Chemother; 1989 Oct; 33(10):1709-13. PubMed ID: 2686547
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cellular uptake, localization and activity of fluoroquinolones in uninfected and infected macrophages.
    Carlier MB; Scorneaux B; Zenebergh A; Desnottes JF; Tulkens PM
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():27-39. PubMed ID: 2258352
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gentamicin-resistant Staphylococcus aureus.
    Lacey RW; Mitchell AA
    Lancet; 1969 Dec; 2(7635):1425-6. PubMed ID: 4188305
    [No Abstract]   [Full Text] [Related]  

  • 47. [The antimicrobial activity and acute toxicity of the polymer salts of gentamycin].
    Solovskiĭ MV; Zaikina NA; Okulova NV; Belokhvostova AT
    Antibiot Khimioter; 2000; 45(6):10-2. PubMed ID: 10904802
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The detection and identification of pathogenic microorganisms: septicemia (author's transl)].
    Tomioka S; Uchida H
    Rinsho Byori; 1979 May; 27(5):361-6. PubMed ID: 491247
    [No Abstract]   [Full Text] [Related]  

  • 49. Replacing MRSA with wild Staphylococcus aureus.
    Grounds M
    Med J Aust; 1990 Jun; 152(11):612-3. PubMed ID: 2348790
    [No Abstract]   [Full Text] [Related]  

  • 50. Controlling antimicrobial-resistant pathogens.
    Jarvis WR
    Infect Control Hosp Epidemiol; 2004 May; 25(5):369-72. PubMed ID: 15188840
    [No Abstract]   [Full Text] [Related]  

  • 51. [Improved detection of significant pathogens in blood culture].
    Arai S
    Kansenshogaku Zasshi; 1985 Mar; 59(3):259-65. PubMed ID: 3925045
    [No Abstract]   [Full Text] [Related]  

  • 52. Colonization of an amputation site by Flavobacterium odoratum after gentamicin therapy.
    Davis JM; Peel MM; Gillians JA
    Med J Aust; 1979 Dec; 2(13):703-4. PubMed ID: 530210
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Staphylococcus aureus bacteremia. Potential impact of a new blood culture technique.
    Sheagren JN
    Arch Intern Med; 1986 Dec; 146(12):2323-4. PubMed ID: 3535718
    [No Abstract]   [Full Text] [Related]  

  • 54. A case of destructive polyarthropathy in a 17-year-old youth following pefloxacin treatment.
    Chevalier X; Albengres E; Voisin MC; Tillement JP; Larget-Piet B
    Drug Saf; 1992; 7(4):310-4. PubMed ID: 1524702
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Isolation and molecular confirmation of a multiresistant catalase-negative Staphylococcus aureus in Nigeria.
    Shittu AO; Lin J; Morrison D; Kolawole DO
    J Infect; 2003 Apr; 46(3):203-4. PubMed ID: 12643875
    [No Abstract]   [Full Text] [Related]  

  • 56. Pefloxacin in clinical practice. Report of a symposium held in Lisbon, 22-23 March 1990. Proceedings.
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():1-229. PubMed ID: 1979554
    [No Abstract]   [Full Text] [Related]  

  • 57. Pefloxacin.
    Bergogne-Bérézin E
    Int J Antimicrob Agents; 1991; 1(1):29-46. PubMed ID: 18611491
    [No Abstract]   [Full Text] [Related]  

  • 58. [Isolation of a Staphylococcus aureus strain resistant to pefloxacin after treatment with pefloxacin and gentamycin].
    Chomarat M; Gerbaud G; Vital-Durand D
    Pathol Biol (Paris); 1990 May; 38(5):474-6. PubMed ID: 2164184
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Course of the resistance of Staphylococcus aureus to pefloxacin. A study based on 782 strains isolated in 1985 and 1986].
    Jean-Pierre H; Boyer G; Jean A; Darbas H
    Pathol Biol (Paris); 1988 Oct; 36(8):956-8. PubMed ID: 3059287
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Gentamicin-resistant Staphylococcus aureus. I. Clinical and bacteriological studies].
    Váţă A; Turcu T; Dimitriu S; Dănilá F; Mihul V; Alexandrescu T
    Rev Med Chir Soc Med Nat Iasi; 1977; 81(4):607-11. PubMed ID: 613408
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.